Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014957
Filing Date
2024-11-08
Accepted
2024-11-08 08:15:32
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q viri-20240930x10q.htm   iXBRL 10-Q 983692
2 EX-10.3 viri-20240930xex10d3.htm EX-10.3 168909
3 EX-10.4 viri-20240930xex10d4.htm EX-10.4 122013
4 EX-10.5 viri-20240930xex10d5.htm EX-10.5 40184
5 EX-10.6 viri-20240930xex10d6.htm EX-10.6 113557
6 EX-31.1 viri-20240930xex31d1.htm EX-31.1 12321
7 EX-31.2 viri-20240930xex31d2.htm EX-31.2 12203
8 EX-32.1 viri-20240930xex32d1.htm EX-32.1 6895
9 EX-32.2 viri-20240930xex32d2.htm EX-32.2 6902
10 GRAPHIC viri-20240930x10q006.jpg GRAPHIC 77348
11 GRAPHIC viri-20240930xex10d5002.jpg GRAPHIC 939
  Complete submission text file 0001558370-24-014957.txt   4977997

Data Files

Seq Description Document Type Size
12 EX-101.SCH viri-20240930.xsd EX-101.SCH 35256
13 EX-101.CAL viri-20240930_cal.xml EX-101.CAL 23992
14 EX-101.DEF viri-20240930_def.xml EX-101.DEF 141018
15 EX-101.LAB viri-20240930_lab.xml EX-101.LAB 316458
16 EX-101.PRE viri-20240930_pre.xml EX-101.PRE 234715
63 EXTRACTED XBRL INSTANCE DOCUMENT viri-20240930x10q_htm.xml XML 484959
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39811 | Film No.: 241438076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)